`_____________________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`————————————————
`
`MYLAN PHARMACEUTICALS INC.,
`Petitioner,
`v.
`BAUSCH HEALTH IRELAND LIMITED,
`Patent Owner.
`
`————————————————
`Case IPR2022-01104
`Patent No. 9,919,024 B2
`————————————————
`
`PETITIONER’S REFUND REQUEST
`37 CFR §1.26
`
`
`
`Case IPR2022-01104
`Patent No. 9,919,024 B2
`
`On June 10, 2022, petitioner Mylan authorized payment of the Inter Partes Post-
`
`Institution fee set under 37 C.F.R. §42.15(a)(2) from its deposit account. Paper 2. The
`
`Patent Trial and Appeal Board subsequently denied Petitioner’s Petition for Inter
`
`Partes Review. Paper 15. Because institution was denied the post-institution fee was
`
`paid in excess of what was required. Accordingly, pursuant to 37 C.F.R. §1.26, Mylan
`
`timely requests a refund of this $22,500 fee.
`
`Petitioner respectfully requests that the Board credit the Post-Institution Fees to
`
`Deposit Account No. 23-2415.
`
`Respectfully submitted,
`
`Dated: September 12, 2023
`
`/Richard Torczon/
`Richard Torczon, Reg. No. 34,448
`Counsel for Mylan Pharmaceuticals Inc.
`
`-2-
`
`
`
`Case IPR2022-01104
`Patent No. 9,919,024 B2
`
`CERTIFICATE OF SERVICE
`
`I certify this paper was served today electronically on Bausch’s counsel at:
`
`Justin J. Hasford
`
`justin.hasford@finnegan.com
`
`Bryan C. Diner
`
`bryan.diner@finnegan.com
`
`Joshua Goldberg
`
`joshua.goldberg@finnegan.com
`
`Kassandra M. Officer Kassandra.officer@finnegan.com
`
`Lauren J. Robinson
`
`lauren.robinson@finnegan.com
`
`Caitlin O’Connell
`
`caitlin.o’connell@finnegan.com
`
`Kyu Yun Kim
`
`kyuyun.kim@finnegan.com
`
`Dated: September 12, 2023
`
`/Robyn Moriarty/
`Robyn Moriarty
`
`-3-
`
`